Non-Commissionable Products Are Coming for MedSup Too | Here's How to Protect Your Book of Business

Kathy and Joanna catch up after a whirlwind few weeks, Platinum Pipeline 2.0 recap, a solo flight with baby Harmony, and Joanna finally opening her own short-term care policy after sitting on the advice for years. Then they get into the topic every Medicare agent needs to hear before AEP hits: non-commissionable products are no longer just a Medicare Advantage problem.Humana and UnitedHealthcare have already gone non-commissionable in parts of the country, Blue Cross Arizona is forcing agents to move contracts to get paid, and now MedSup carriers are starting to follow. Kathy and Joanna talk through what this actually means for independent agents, why "staying in your county" isn't a safe strategy anymore, and how diversifying by location and by product line is the only way to protect your income long-term.They also get real about the tools they've dropped (Connecture, RetireFlow), the workaround Kathy's using now that Medicare.gov data isn't reliable, and a compliance detail a lot of agents don't realize: you don't need a signed Scope of Appointment to talk about health products like dental, vision, or short-term care during a Medicare meeting.In this episode:Platinum Pipeline 2.0 recap, the speakers, the lessons, and what Joanna's implementing from itWhy non-commissionable Medicare Advantage plans are just the beginningMedSup carriers going non-commissionable in states like New YorkThinking beyond your county (or even your state) to protect your businessWhy Kathy dropped her "free quote" service using Health Sherpa and Medicare.govThe compliance rule most agents don't know about health product cross-sellingJoanna's personal story on why every client, even MedSup clients, should be offered a cancer policy If you sell Medicare and you haven't thought about what happens when your best-selling plans stop paying commission, this episode is your wake-up call. Follow Insurance Business Babes so you never miss an episode.